Jesus Garcia-Donas
Jesus Garcia-Donas
Head of the Gynecological, Genitourinary and Skin Cancer Unit Hospital Madrid Norte Sanchinarro
Dirección de correo verificada de hmhospitales.com
Título
Citado por
Citado por
Año
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
6962017
Erdafitinib in locally advanced or metastatic urothelial carcinoma
Y Loriot, A Necchi, SH Park, J Garcia-Donas, R Huddart, E Burgess, ...
New England Journal of Medicine 381 (4), 338-348, 2019
3122019
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre …
J Garcia-Donas, E Esteban, LJ Leandro-García, DE Castellano, ...
The lancet oncology 12 (12), 1143-1150, 2011
2572011
Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer
RL Coleman, GF Fleming, MF Brady, EM Swisher, KD Steffensen, ...
New England Journal of Medicine 381 (25), 2403-2415, 2019
2312019
Metastatic prostate cancer
O Sartor, JS de Bono
New England Journal of Medicine 378 (7), 645-657, 2018
1932018
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity
S Leskelä, C Jara, LJ Leandro-Garcia, A Martinez, J Garcia-Donas, ...
The pharmacogenomics journal 11 (2), 121-129, 2011
1362011
Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
EL Goode, MS Block, KR Kalli, RA Vierkant, W Chen, ZC Fogarty, ...
JAMA oncology 3 (12), e173290-e173290, 2017
1142017
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
O Calvete, P Martinez, P Garcia-Pavia, C Benitez-Buelga, ...
Nature communications 6 (1), 1-12, 2015
982015
Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis
I Diaz-Padilla, N Romero, E Amir, X Matias-Guiu, E Vilar, F Muggia, ...
Critical reviews in oncology/hematology 88 (1), 154-167, 2013
932013
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
E Grande, J Capdevila, D Castellano, A Teulé, I Durán, J Fuster, I Sevilla, ...
Annals of oncology 26 (9), 1987-1993, 2015
882015
Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma
C Prior, JL Perez-Gracia, J Garcia-Donas, C Rodriguez-Antona, ...
PloS one 9 (1), e86263, 2014
792014
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
J Garcia-Donas, LJ Leandro-Garcia, AG Del Alba, M Morente, I Alemany, ...
Annals of oncology 24 (9), 2409-2414, 2013
752013
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma
MHM Diekstra, JJ Swen, E Boven, D Castellano, H Gelderblom, ...
European urology 68 (4), 621-629, 2015
712015
Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB
L Minig, MG Patrono, N Romero, JFR Moreno, J Garcia-Donas
World journal of clinical oncology 5 (2), 86, 2014
672014
Strategies to design clinical studies to identify predictive biomarkers in cancer research
JL Perez-Gracia, MF Sanmamed, A Bosch, A Patiño-Garcia, KA Schalper, ...
Cancer treatment reviews 53, 79-97, 2017
602017
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy
M Apellániz-Ruiz, MY Lee, L Sánchez-Barroso, G Gutiérrez-Gutiérrez, ...
Clinical Cancer Research 21 (2), 322-328, 2015
552015
Circulating and disseminated tumor cells in ovarian cancer: a systematic review
N Romero-Laorden, D Olmos, T Fehm, J Garcia-Donas, I Diaz-Padilla
Gynecologic oncology 133 (3), 632-639, 2014
492014
Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women
L Minig, L Chuang, MG Patrono, JM Cárdenas-Rebollo, J García-Donas
Journal of minimally invasive gynecology 22 (4), 653-657, 2015
462015
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
PF Rambau, RA Vierkant, MP Intermaggio, LE Kelemen, MT Goodman, ...
The Journal of Pathology: Clinical Research 4 (4), 250-261, 2018
362018
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response
J García-Donas, B Beuselinck, L Inglada-Pérez, O Graña, P Schöffski, ...
JCI insight 1 (10), 2016
342016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20